04
JUN
2019
Highlights Of NW Bio’s Program Update In The Industry Expert Theater Presentation At ASCO
Comments : Off
BETHESDA, Md., June 4, 2019 /PRNewswire/ — Northwest Biotherapeutics (OTCQB: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today highlights from Dr. Marnix Bosch’s Program Update in the Industry Expert Theater presentation at the 55th annual ASCO Conference, which was publicly webcast and was posted on the home page of the Company’s websit... Read More